Biotech Growth N V - Apr 18, 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Stock symbol: BDTX
Transactions as of: Apr 18, 2022
Transactions value $: $980,580
Form type: 4
Date filed: 4/20/2022, 12:56 PM
Previous filing: Apr 14, 2022
Next filing: Apr 29, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$494K	+150K	+3.76%	$3.29	4.14M	Apr 18, 2022	Direct
transaction	BDTX	Common Stock	Purchase	$487K	+150K	+3.62%	$3.24	4.29M	Apr 19, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.